A new modified live equine influenza virus vaccine: Phenotypic stability, restricted spread and efficacy against heterologous virus challenge

Equine Veterinary Journal

Volumn 33, Issue 7, 2001, Pages 630-636

  Chambers, T M ^a   Holland, R E ^a   Tudor, L R ^a   Townsend, H G G ^b   Cook, A ^b   Bogdan, J ^b   Lunn, D P ^c   Hussey, S ^c   Whitaker Dowling, P ^d   Youngner, J S ^d   Sebring, R W ^e   Penner, S J ^e   Stiegler, G L ^e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e HESKA CORPORATION   (United States)

Author keywords

Antigenic drift; Backpassage; Challenge; Cold adapted; Horse; Intranasal; Modified live virus

Indexed keywords

ANIMALIA; EQUIDAE; EQUINE INFLUENZA VIRUS; EQUUS CABALLUS; INFLUENZA VIRUS;

INFLUENZA VACCINE; LIVE VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; DISEASE TRANSMISSION; FEMALE; HORSE; HORSE DISEASE; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; INTRANASAL DRUG ADMINISTRATION; MALE; NEBULIZER; PHENOTYPE; SAFETY; STANDARD; TIME; TREATMENT OUTCOME; VACCINATION; VIRUS CULTURE; VIRUS SHEDDING;

ADMINISTRATION, INTRANASAL; ANIMAL; FEMALE; HORSE DISEASES; HORSES; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA VACCINE; MALE; NEBULIZERS AND VAPORIZERS; PHENOTYPE; SAFETY; SERIAL PASSAGE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TREATMENT OUTCOME; VACCINATION; VACCINES, ATTENUATED; VIRUS SHEDDING;

EID: 0035516230     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516401776249291     Document Type: Article

References (19)

1. Anon (1996) Equine influenza. In: OIE Manual of Standards for Diagnostic Tests and Vaccines, 3rd edn., Office International des Epizooties, Paris. pp 409-419.
2. Belshe, R.B., Gruber, W.C., Mendelman P.M., Cho, I., Reisinger, K., Block, S.L., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D.I., Hayden, F.G., Zangwill, K., Yan, L. and Wolff, M. (2000) Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J. Pediatr. 136, 168-175.
3. Bogdan, J.R., Morley, P.S., Townsend, H.G. and Haines, D.M. (1992) Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses. Can. J. vet. Res. 57, 126-130.
4. Chambers, T.M., Holland, R.E. and Lai, A.C.K. (1995) Equine influenza - Current veterinary perspectives. Parts 1 and 2. Equine Pract. 17, 19-23 (issue 8), 26-30 (issue 10).
5. Daly, J.M., Lai, A.C.K., Binns, M.M., Chambers, T.M., Barrandeguy, M. and Mumford, J.A. (1996) Recent worldwide antigenic and genetic evolution of equine H3N8 influenza A viruses. J. Gen. Virol. 77, 661-671.
6. Holland, R.E., Conboy, H.S., Berry, D.B., Fallon, E.H., Powell, D.G., Tudor, L.R., and Chambers, T.M. (1999) Age dependence of foal vaccination for equine influenza: new evidence from the USA. In: Equine Infectious Diseases VIII, Eds: U. Wernery, J.F. Wade, J.A. Mumford and O.-R. Kaaden, R&W Publications Ltd, Newmarket, pp 547-548.
7. Horohov, D.W., Dimock, A, Guirnalda, P., Folsom, R.W., McKeever, K.H. and Malinowski, K. (1999) Effect of exercise on the immune response of young and old horses. Am. J. vet. Res. 60, 643-647
8. John, T.J. and Fulginiti, V.A. (1966) Parainfluenza 2 virus: Increase in haemagglutinin titer on treatment with Tween-80 and ether. Proc. Soc. expt. Biol. Med. 212, 109-111.
9. Lai, A.C.K., Lin, Y.P., Powell, D.G., Shortridge, K.F., Webster, R.G., Daly, J. and Chambers, T.M. (1994) Genetic and antigenic analysis of the influenza virus responsible for the 1992 Hong Kong equine influenza epizootic. Virol. 204, 673-679.
10. Lai, A.C.K., Chambers, T.M., Holland, R.E. Jr., Morley, P.S., Haines, D., Townsend, H.G.G. and Barrandeguy, M. (2001) Multiple evolutionary lineages of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch. Virol. 146, 1063-1074.
11. Lunn, D., Horohov, D., Hussey, S., Whitaker-Dowling, P., Youngner, J., Chambers, T., Holland, R., Rushlow, K, and Sebring, R. (1999) A potent modified-live equine influenza virus vaccine: safe even after exercise-induced immunosuppression. Proc. Am. Ass. equine Practnrs. 45, 43-44.
12. Lunn, D.P., Hussey, S., Sebring, R., Rushlow, K.E., Radecki, S., Whitaker-Dowling, P., Younger, J.S., Chambers, T.M., Holland, R.E. Jr. and Horohov, D.W. (2001) Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. J. Am. vet. med. Ass. 218, 900-906.
13. Mumford, J.A., Hannant, D. and Jesset, D.M. (1990) Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Epidemiol. Infect. 100, 501-510.
14. Townsend, H.G.G., Morley, P.S., Newton, J.R., Wood, J.L.N., Haines, D.M. and Mumford, J.A. (1999a) Measuring serum antibody as a method of predicting infection and disease in horses during outbreaks of influenza. In: Equine Infectious Diseases VIII, Eds: U. Wernery, J.F. Wade, J.A. Mumford and O.-R. Kaaden, R&W Publications, Newmarket, pp 33-37.
15. Townsend, H., Cook, A., Watts, T., Bogdan, J., Haines, D., Griffin, S., Chambers, T., Holland, R., Whitaker-Dowling, P., Youngner, J., Penner, S. and Sebring, R. (1999b) Efficacy of a cold-adapted, modified-live virus influenza vaccine: a double-blind challenge trial. Proc. Am. Ass. equine Practnrs. 45, 41-42.
16. Townsend, H.G.G., Penner, S. J., Watts, T.C., Cook, A, Bogdan, J., Haines, D.M., Griffin, S., Chambers, T., Holland, R.E., Whitaker-Dowling, P., Youngner, I.S. and Sebring, R.W. (2001) Efficacy of a modified-live, temperature sensitive, intranasal vaccine against equine influenza: challenge trials. Equine vet. J. 33, 637-643.
17. Wilson, W.D. and Robinson, D. (2000) Field safety of a modified-live, cold-adapted intranasal equine influenza vaccine (HESKA Flu Avert IN vaccine) in horses. J. Equine vet. Sci. 20, 8-10.
18. Youngner, J.S., Treanor, J.J., Betts, R.F. and Whitaker-Dowling, P. (1994) Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans. J. Clin. Microbiol. 32, 750-754.
19. Youngner, J.S., Whitaker-Dowling, P., Chambers, T.M., Rushlow, K.E. and Sebring, R.J. (2001) Derivation and characterization of a live attenuated equine influenza vaccine virus. Am. J. vet. Res. 62, 1290-1294.